对于心房动的消化和节奏策略:节奏方式,消化方法和对患者结果的影响
Pietro Palmisano1, Cosimo Mandurino2, Antonio Parlavecchio3
1Cardiology Unit, "Card. G. Panico" Hospital, Tricase (Le), Italy.
Expert review of medical devices
|January 9, 2025
概括
消化和节奏 (A&P) 策略改善了心房患者的生活质量. 导电系统节奏 (CSP) 正在成为A&P治疗中双心脏节奏 (BVP) 的优越替代方案.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械 医疗器械
背景情况:
- 切除和节奏 (A&P) 策略,涉及心脏起器植入,其次是心房结切除 (AVJA),已被证明对症状性,耐心心房的治疗有效.
- 尽管有好处,但A&P策略在临床实践中仍未得到充分利用.
- 节奏模式的选择 (RV,BVP,CSP) 显著影响患者的结果.
研究的目的:
- 审查关于心房动的A&P策略的当前证据.
- 专注于节奏模式,特别是传导系统节奏 (CSP) 对患者结果的影响.
- 讨论A&P治疗的指示,技术方面以及未来的方向.
主要方法:
- 审查当前的科学文献和临床证据.
- 在A&P战略中,分析与不同节奏模式相关的患者结果.
- 对心房结切除 (AVJA) 和设备编程的技术考虑的评估.
主要成果:
- 导电系统节拍 (CSP) 与双心脏节拍 (BVP) 相比,显示出可比或更高的有效性和安全性.
- 在A&P程序中,CSP正在成为BVP的一个有希望的替代方案.
- 最佳时间,AVJA的方法和设备编程对于成功的A&P结果至关重要.
结论:
- 导电系统步调 (CSP) 准备成为A&P候选人的标准步调模式.
- 更广泛地采用CSP可以增加A&P战略在临床实践中的利用.
- 进一步的研究和证据将巩固CSP在心房的A&P治疗中的作用.
相关概念视频
Disturbances in Heart Rhythm
895
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
895
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Mechanism of Cardiac Arrhythmias
886
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
886
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
770
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
770


